Development of PNEC innervation and neuroplasticity after early life insult

早期生活损伤后 PNEC 神经支配和神经可塑性的发展

基本信息

  • 批准号:
    10089028
  • 负责人:
  • 金额:
    $ 42.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-05-01 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT How pulmonary neuroendocrine cells (PNECs) become innervated and to what extent nerves regulate PNEC function in development and diseases are open and basic questions for the field. The objective of this proposal is to address these fundamental issues and to assess the key role of neurotrophin 4 (NT4) in these events. Using a NT4-/- mouse line and a neonatal mouse model of allergen exposure, we generated preliminary data leading to 3 hypotheses that will be studied in this proposal: 1) NT4 is required for PNEC innervation during development and for the increases in PNEC innervation following early life insults; 2) early life allergen exposure alters the function of sensory afferents and efferent nerves that innervate PNECs thereby causing deregulated γ-aminobutyric acid (GABA) secretion and long-term goblet cell metaplasia; 3) pulmonary mast cells are a candidate source of elevated NT4 levels following early life allergen exposure. To summarize, we found that NT4 was expressed by PNECs during postnatal development and acted as a trophic factor for the innervating nerves to establish connection. Allergen exposure to developing, postnatal lungs aberrantly elevated the levels of NT4. Under this pathological condition, we discovered that PNEC innervation was increased associated with prolonged goblet cell metaplasia. Notably, PNECs were the only cell source of GABA in lungs, a signal essential for allergen-induced goblet cell metaplasia in mouse models and associated with mucous overproduction in human asthmatics and smokers. In addition, NT4 was required for PNEC hyperinnervation and deregulated GABA secretion, consistent with the established paradigm in other neuroendocrine systems that nerves regulate endocrine secretion. These preliminary findings point to an essential role for NT4 in PNEC innervation during development and neuroplasticity following early life injury, which will be extensively characterized by comparing the pattern and degree of PNEC innervation between wild type and NT4-/- mice with and without allergen exposure using markers for different types of nerves (Aim 1). To connect NT4-induced PNEC hyperinnervation to prolonged goblet cell metaplasia following early life allergen exposure, proposed experiments in Aim 2 will assess functional changes in sensory afferents and efferent signals that induce GABA secretion from PNECs and their relationships to NT4. Lastly, given the central role of NT4 in aberrant PNEC innervation under pathological conditions, we examined NT4 expression in injured lungs. We found an enlarged, activated mast cell population expresses NT4 during early life allergen exposure. Whether pulmonary mast cells contribute to PNEC hyperinnervation by producing NT4 will be evaluated (Aim 3). To further enhance disease relevance, we will validate key findings from the mouse work in infant primate models of injury and human lung samples. Together, this proposal investigates complex interactions between nerves, PNECs, and inflammation during postnatal development and injury. Our findings indicate that the pathogenesis of chronic airway diseases, such as asthma, may involve disrupted developmental processes following early episodes of insults. We expect that completion of the proposed studies will provide fundamental knowledge about how the pulmonary neuroendocrine system forms and functions. Identification of the mechanisms along the nerve-PNEC axis underlying mucous overproduction may lay the foundation for the discovery of new treatment strategies.
摘要 肺神经内分泌细胞(PNEC)如何受到神经支配以及神经在多大程度上调节PNEC 在发育和疾病中的功能是该领域的开放和基本问题。的目的 我们的建议是解决这些基本问题,并评估神经营养因子4(NT 4)在这些方面的关键作用。 事件使用NT 4-/-小鼠系和新生小鼠过敏原暴露模型,我们产生了 初步数据导致本提案将研究3个假设:1)PNEC需要NT 4 神经支配在发展过程中和增加PNEC神经支配后,早期生活的侮辱; 2)早期 生活变应原暴露改变了支配PNEC的感觉传入和传出神经的功能 从而导致γ-氨基丁酸(GABA)分泌失调和长期杯状细胞化生; 3) 肺肥大细胞是在生命早期暴露于过敏原后升高的NT 4水平的候选来源。到 总之,我们发现NT 4在出生后发育过程中由PNEC表达,并作为营养因子发挥作用, 使支配神经建立连接的因素。过敏原暴露于发育中的出生后肺部 异常地升高了NT 4的水平在这种病理状态下,我们发现PNEC的神经支配 与杯状细胞化生延长相关。值得注意的是,PNEC是唯一的细胞来源, 肺中的GABA是小鼠模型中过敏原诱导杯状细胞化生所必需的信号, 与人类哮喘患者和吸烟者的粘液分泌过剩有关。此外,PNEC需要NT 4 神经支配过度和GABA分泌失调,与其他研究中建立的范式一致。 神经内分泌系统,即神经调节内分泌。这些初步调查结果表明, NT 4在发育过程中PNEC神经支配和早期生命损伤后的神经可塑性中的重要作用, 这将通过比较PNEC神经支配的模式和程度来广泛表征, 使用不同类型神经的标记物,在有和没有变应原暴露的情况下,野生型和NT 4-/-小鼠(Aim 1)。将NT 4诱导的PNEC神经支配过度与生命早期延长的杯状细胞化生联系起来 过敏原暴露,目标2中提出的实验将评估感觉传入的功能变化, 传出信号,诱导GABA分泌的PNEC和他们的关系NT 4。最后,鉴于 在病理条件下,NT 4在异常PNEC神经支配中的中心作用,我们检测了NT 4的表达 受伤的肺部。我们发现,在早期生活过敏原中,肥大细胞群扩大,活化,表达NT 4 exposure.肺肥大细胞是否通过产生NT 4而促进PNEC的神经支配, 评价(目标3)。为了进一步增强疾病的相关性,我们将验证小鼠工作的关键发现, 婴儿灵长类动物损伤模型和人肺样本。这项提案共同探讨了复杂的 在出生后发育和损伤过程中,神经、PNEC和炎症之间的相互作用。我们的研究结果 表明慢性气道疾病如哮喘的发病机制可能涉及干扰, 在早期侮辱事件之后的发育过程。我们期望完成拟议的 研究将提供有关肺神经内分泌系统如何形成的基础知识, 功能协调发展的粘液分泌过多的神经-PNEC轴沿着机制的鉴定 可能为发现新的治疗策略奠定基础。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Targeting acetylcholine receptor M3 prevents the progression of airway hyperreactivity in a mouse model of childhood asthma.
靶向乙酰胆碱受体 M3 可预防儿童哮喘小鼠模型中气道高反应性的进展。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xingbin Ai其他文献

Xingbin Ai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xingbin Ai', 18)}}的其他基金

COVID-19 imprints airway basal cells to impair epithelium regeneration
COVID-19 印记气道基底细胞,损害上皮再生
  • 批准号:
    10738549
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
Age-related mechanisms of T helper 2 memory in the early lung
早期肺部辅助T辅助细胞2记忆的年龄相关机制
  • 批准号:
    10316809
  • 财政年份:
    2021
  • 资助金额:
    $ 42.77万
  • 项目类别:
Age-related mechanisms of T helper 2 memory in the early lung
早期肺部辅助T辅助细胞2记忆的年龄相关机制
  • 批准号:
    10447694
  • 财政年份:
    2021
  • 资助金额:
    $ 42.77万
  • 项目类别:
Age-related mechanisms of T helper 2 memory in the early lung
早期肺部辅助T辅助细胞2记忆的年龄相关机制
  • 批准号:
    10653092
  • 财政年份:
    2021
  • 资助金额:
    $ 42.77万
  • 项目类别:
Development of PNEC innervation and neuroplasticity after early life insult
早期生活损伤后 PNEC 神经支配和神经可塑性的发展
  • 批准号:
    9310524
  • 财政年份:
    2017
  • 资助金额:
    $ 42.77万
  • 项目类别:
Identification of Sulfs as therapeutic targets for the treatment of age-impaired skeletal muscle regeneration
确定磺基作为治疗年龄受损骨骼肌再生的治疗靶点
  • 批准号:
    8918172
  • 财政年份:
    2014
  • 资助金额:
    $ 42.77万
  • 项目类别:
The Fetal Lung Mesothelial Differentiation Program
胎儿肺间皮分化计划
  • 批准号:
    8854132
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
The Fetal Lung Mesothelial Differentiation Program
胎儿肺间皮分化计划
  • 批准号:
    8462105
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
The Fetal Lung Mesothelial Differentiation Program
胎儿肺间皮分化计划
  • 批准号:
    9069951
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
The Fetal Lung Mesothelial Differentiation Program
胎儿肺间皮分化计划
  • 批准号:
    8712548
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 42.77万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 42.77万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 42.77万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 42.77万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 42.77万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 42.77万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 42.77万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 42.77万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 42.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了